eClinical Tech News

Vyne Therapeutics and Yarrow Bioscience will merge in an all-stock transaction to form Yarrow Bioscience, which plans to trade...

Sagimet Biosciences has secured a global, exclusive license from Teva’s TAPI Technology & API Services to use innovative forms...

Veru has secured FDA feedback that clarifies a regulatory path for enobosarm as an adjunct to GLP-1 receptor agonists...

Sapu Nano, a 45% owned joint venture of Oncotelic Therapeutics, reported new data at the 2025 San Antonio Breast...

Onco3R Therapeutics has completed the first multiple-ascending-dose cohort in a Phase 1 study of its oral SIK3 inhibitor, O3R-5671,...

Biogen and Stoke Therapeutics unveiled new clinical and biomarker data for zorevunersen, an investigational antisense oligonucleotide for Dravet syndrome,...

XOMA Royalty Corporation has completed its acquisition of Mural Oncology plc via an Irish High Court–sanctioned scheme of arrangement,...

Rezolute reported topline data from its Phase 3 sunRIZE study in congenital hyperinsulinism showing that ersodetug did not meet...

Novartis will flood the 2025 ASH and SABCS meetings with more than 70 data readouts, including 11 oral presentations...

HUTCHMED will deliver a coordinated slate of oncology and hematology readouts across ESMO Asia and ASH in early December,...